Correlation Between Enfusion and EPlus
Can any of the company-specific risk be diversified away by investing in both Enfusion and EPlus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and EPlus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enfusion and ePlus inc, you can compare the effects of market volatilities on Enfusion and EPlus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of EPlus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and EPlus.
Diversification Opportunities for Enfusion and EPlus
Very good diversification
The 3 months correlation between Enfusion and EPlus is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and ePlus inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ePlus inc and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with EPlus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ePlus inc has no effect on the direction of Enfusion i.e., Enfusion and EPlus go up and down completely randomly.
Pair Corralation between Enfusion and EPlus
Given the investment horizon of 90 days Enfusion is expected to generate 0.71 times more return on investment than EPlus. However, Enfusion is 1.4 times less risky than EPlus. It trades about 0.07 of its potential returns per unit of risk. ePlus inc is currently generating about -0.08 per unit of risk. If you would invest 1,047 in Enfusion on December 28, 2024 and sell it today you would earn a total of 67.00 from holding Enfusion or generate 6.4% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Enfusion vs. ePlus inc
Performance |
Timeline |
Enfusion |
ePlus inc |
Enfusion and EPlus Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enfusion and EPlus
The main advantage of trading using opposite Enfusion and EPlus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, EPlus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EPlus will offset losses from the drop in EPlus' long position.Enfusion vs. ON24 Inc | Enfusion vs. Paycor HCM | Enfusion vs. E2open Parent Holdings | Enfusion vs. Braze Inc |
EPlus vs. Kopin | EPlus vs. Corning Incorporated | EPlus vs. Ouster, Common Stock | EPlus vs. LightPath Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |